阿拉巴马州批准了三张药房许可证,为2026年春季之前医疗用大麻的获取铺平了道路。 Alabama approved three dispensary licenses, paving way for medical cannabis access by spring 2026.

阿拉巴马州大麻医疗委员会已经批准了三家公司的药房许可证,这是向启动国家大麻医疗计划迈出的关键一步,预计产品将在2026年春天之前推出。 The Alabama Medical Cannabis Commission has approved dispensary licenses for three companies, a key step toward launching the state’s medical marijuana program, with products expected by spring 2026. 该决定解决了重大的监管障碍,允许病人入学和医生认证进行。 The decision resolves a major regulatory hurdle, allowing patient enrollment and physician certification to proceed. 每个领有执照的公司最多可以经营三个药房,第四个许可证正在等待颁发。 Each licensed company can operate up to three dispensaries, and a fourth license is pending. 虽然种植者和加工者已经获得许可证,但在目前的法律争端中,5个综合种子到销售许可证仍未获得。 While cultivators and processors are already licensed, five integrated seed-to-sale licenses remain unawarded amid ongoing legal disputes. 该方案于2021年获得批准,遵循全国趋势,阿拉巴马州加入40个州,允许使用医用大麻。 The program, authorized in 2021, follows a national trend as Alabama joins 40 states allowing medical cannabis use.